Anonymous
Guest
Anonymous
Guest
Eli Lilly could learn so much from Novartis. Like diversifying a little so that the employees are not discarded when the current obsession with blockbuster CNS drugs ends with the patents...
I work for Sanofi and let me tell you diversification will not save the pharmaceutical sales representative role in this industry. Our CEO Chris Viehbacher has been on the diversification kick ever since he took the helm of Sanofi, but that diversification is not going to lead to more opportunities for sales representatives in the future. When you're buying companies that have generic products or products that do not need sales representation how does that translate into employment for a sales rep? In addition, digital tools are fast replacing representatives for sampling products in the doctors' offices. Have you seen the new digital sampling tool from Epocrates? this profession is finished people, diversification will not save you.
Your an idiot- good sales people will always be needed. People always prefer to buy from people.
Your an idiot- good sales people will always be needed. People always prefer to buy from people.
I work for Sanofi and let me tell you diversification will not save the pharmaceutical sales representative role in this industry. Our CEO Chris Viehbacher has been on the diversification kick ever since he took the helm of Sanofi, but that diversification is not going to lead to more opportunities for sales representatives in the future. When you're buying companies that have generic products or products that do not need sales representation how does that translate into employment for a sales rep? In addition, digital tools are fast replacing representatives for sampling products in the doctors' offices. Have you seen the new digital sampling tool from Epocrates? this profession is finished people, diversification will not save you.